Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Researchers are investigating whether being right handed is due to genetics or other factors.

By HospiMedica International staff writers
Posted on 03 Nov 2008
A multidisciplinary team of researchers is evaluating whether tissue optical spectroscopy can be utilized for early cancer detection in the pancreas during minimally invasive endoscopic diagnostic procedures.

Their objective is to help physicians distinguish between cancerous tissue transformations and benign changes in tissues due to different diseases, such as pancreatitis. More...
Doing this can speed an accurate diagnosis and treatment to generate better patient outcomes. Pancreatic cancer is the fourth leading cause of cancer death in the United States alone; 95% of all patients diagnosed with the disease will die from it, more than half within six months of diagnosis.

"Until better treatment approaches can be developed, the only opportunity to change disease-associated mortality in pancreatic cancer patients is earlier diagnosis,” explained Mary-Ann Mycek, associate professor and associate chair of the University of Michigan (Ann Arbor, USA), department of biomedical engineering. "Current diagnostic methods have not been able to provide accurate diagnoses in early stages of the disease.”

The Michigan team's goal is to develop an optical technique to detect pancreatic cancer in patients at early stages--a development that could greatly improve the chances of patient survival by meeting the critical, unmet need of accurately differentiating malignant masses from benign pancreatitis. Such improved diagnostic accuracy could also appropriately triage patients, thereby preventing those without cancer from having unnecessary surgery.

To accomplish this, investigators used a multimodal optical spectroscopy approach based on observing reflectance and fluorescence properties of pancreatic tissue samples. Spectral analysis showed significant differences between normal, pancreatitis (inflammation), and cancerous tissues, thus suggesting noninvasive diagnostic possibilities for distinguishing among disease states.

The theory behind optically based diagnostics is this: in the body, the presence of disease alters tissue properties, such as local biochemistry and structure. Optically based disease diagnostic techniques can probe microscopic tissue alterations for signatures of disease, thereby leading to noninvasive diagnostics in living patients. Once detected optically, such diseased tissue may be treated. Because optical techniques do not require the removal of tissue, they could represent an advance in patient care over the invasive practice of tissue biopsy.

The study's findings were presented at Frontiers in Optics 2008 (FiO), the 92nd annual meeting of the Optical Society (OSA), which was held October 19-23, 2008, in Rochester, NY, USA.

Related Links:
University of Michigan



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.